CD274 and non-small cell lung carcinoma: Notably, NSCLC patients receiving standard EGFR-tyrosine kinase inhibitors (TKIs) treatment showed downregulated EGFR-induced PD-L1 expression and upregulated IFN-γ-induced PD-L1 expression.